Adding cetuximab to chemotherapy doubles response rate in hard-to-treat breast cancer
Tuesday, October 12, 2010 - 14:03
in Health & Medicine
European researchers have proven for the first time that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat triple-negative breast cancer.